Ari Bousbib - Quintiles IMS Insider

Quintiles IMS Holdings Inc -- USA Stock  

USD 103.48  0.9  0.88%


Mr. Ari Bousbib is a Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as chairman and CEO of IMS Health. In 2014, he led the successful IPO of the company. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporationrationration, an aerospace, defense and building industries company. From 2008 until 2010, he served as President of UTCs Commercial Companies, including Otis Elevator Company, Carrier Corporationrationration, UTC Fire Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002 he served as its Chief Operating Officer. Previously, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the Presidents Commission on White House Fellowships
Age: 55  Director Since 2016  MBA    
Bousbib holds a MS Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University.

Ari Bousbib Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.12 % which means that for every 100 dollars spent on asset it generated profit of $4.12. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 2.25 % implying that it made 2.25 on every $100 invested by shareholders.
The company has accumulated 8.97 B in total debt with debt to equity ratio (D/E) of 115.3 implying that the company may be unable to produce cash to meet its debt commitments. Quintiles IMS Holdings Inc has Current Ratio of 1.21 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives


Christopher CoughlinAllergan plc
Jill SmithEndo International plc
Ron TaylorAllergan plc
Arthur HigginsEndo International plc
Samuel ScottAbbott Laboratories
Robert MalchioneBio Rad Laboratories Inc
William SpenglerEndo International plc
Elaine UllianVertex Pharmaceuticals Incorpor
John StrattonAbbott Laboratories
Phebe NovakovicAbbott Laboratories
Roxanne AustinAbbott Laboratories
Alice SchwartzBio Rad Laboratories Inc
David GreenwayVertex Pharmaceuticals Incorpor
Daniel StarksAbbott Laboratories
Adriane BrownAllergan plc
Sharad MansukaniEndo International plc
Robert AlpernAbbott Laboratories
Catherine KlemaAllergan plc
James FarrellAbbott Laboratories
Edward LiddyAbbott Laboratories
Margaret McGlynnVertex Pharmaceuticals Incorpor

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles IMS Holdings Inc (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

Did you try this?

Run Premium Stories Now

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Hide  View All  NextLaunch Premium Stories
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Quintiles IMS Holdings Inc to your portfolio

Top Management

Quintiles IMS Holdings Leadership Team
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
Anand MD, Executive
Christopher Gordon, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Thomas Pike, CEO
Fred Cohen, Director
Richard Staub, President
MRCA MBBS, Executive
Mireille Gillings, Director, Ph.D
Richard Relyea, Director
Ronald Rittenmeyer, Director, MBA
Kevin Knightly, President

Stock Performance

Quintiles IMS Performance Indicators